Advertisement

Journal of Cancer Research and Clinical Oncology

, Volume 111, Supplement 1, pp S147–S147 | Cite as

A randomized phase-III-study on dtic, levamisole, and placebo as adjuvant treatment of high risk stage i primary helanoma

  • E. Macher
  • U. R. Kleeberg
  • F. Lejeune
  • Ph. Rümke
  • M. Prade
  • D. Thomas
  • S. Suciu
Deutsche Krebsgesellschaft Proceedings 18th National Cancer Congress of the German Cancer Society March 4–8, 1986 Munich, Federal Republic of Germany

Keywords

Melanoma Levamisole Primary Melanoma Neuroectodermal Tumor High Risk Stage 

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • E. Macher
    • 1
  • U. R. Kleeberg
    • 1
  • F. Lejeune
    • 1
  • Ph. Rümke
    • 1
  • M. Prade
    • 1
  • D. Thomas
    • 1
  • S. Suciu
    • 1
  1. 1.Haemät.-onkol. Praxis AltoneHamburg 50Germany

Personalised recommendations